Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-21T07:46:04.376Z Has data issue: false hasContentIssue false

P03-34 - First European Studies on Acupuncture and Schizophrenia: First Results

Published online by Cambridge University Press:  17 April 2020

P. Bosch
Affiliation:
Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands
P. Ronan
Affiliation:
Social Work, Community & Mental Health, Canterbury Christ Church University, Canterbury, UK
N. Quinton
Affiliation:
Broadway North Day Centre, Walsall Teaching Primary Care Trust, Birmingham, UK
D. Harbinson
Affiliation:
Canterbury Christ Church University, Canterbury, UK
M. van den Noort
Affiliation:
Free University of Brussels, Brussels, Belgium

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives

This presentation will compare preliminary results from the first two European studies being carried out on acupuncture and schizophrenia, one in the UK and one in Germany. Statistical comment will be made on comparable study outcomes and there will be discussion on the methodological successes and challenges of the studies. Implications for future research on acupuncture on acupuncture and schizophrenia in European mental health settings will be explored.

Methods

Both studies are using a case study approach, incorporating a wide range of methods, in order to explore the possible effects that acupuncture may have on schizophrenia. Amongst the methods used to explore the possible effect that acupuncture might have, both studies are using the Positive and Negative Symptom Scale (PANSS), and the Pittsburgh Sleep Quality Index (PSQI).

Results

The intervention phase of both studies is currently underway. First results of the PANSS and the PSQI will be presented.

Conclusions

These are the first attempts to carry out research on the possibility of acupuncture as a treatment or an adjunct treatment for schizophrenia in Europe. It is hoped that these results will indicate the way forward in terms of analysis of the remainder of the outcomes of the study and there will be some indication for the possibility for future research in this area.

Type
Psychotic disorders / Schizophrenia
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.